Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Älmby Entreprenad Aktiebolag (”Älmby Entreprenad”)
Mandate

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Älmby Entreprenad Aktiebolag (”Älmby Entreprenad”)

September 28, 2021 M&A Real Estate and Construction Employment and Benefits EU, Competition and Regulatory Banking and Finance

Älmby Entreprenad is based in Älmhult, has 115 employees and has yearly sales around SEK 500 million. Älmby Entreprenad offers unique solutions in ground construction but also provides demolition and drilling services.

Vinge’s team consisted primarily of partner Christina Kokko and associates Manne Bergström, Carl Fredrik Wachtmeister, Nando Basic and Ellen Åkerdahl Flygt (M&A), Isak Willborg and Mario Saad (Agreements), Ebba Svenburg (Employment), Jolinn Uhlin (Banking & Finance), Karolina Cohrs and Ulf Pyk (Real Property & Environment), Johan Wahlbom and Victoria Fredén (Competition) and Sara Dahlros Sköld (VDR-assistant).

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025